Health Pharma Querétaro

Juriquilla 76230

4 studies enrolling now · 5 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Crohn's Disease, Distal Sensory Polyneuropathy, Neoplasm Metastasis, Neuropathic Pain, Obesity or Overweight, Ulcerative Colitis, Urinary Incontinence,Stress

Studies at this site

• Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study — Recruiting now
• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight — Recruiting now
• A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight — Recruiting now
• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer — Recruiting now
• Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy — Completed